135 related articles for article (PubMed ID: 12066133)
41. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
[TBL] [Abstract][Full Text] [Related]
42. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function.
Chouhan VD; De La Cadena RA; Nagaswami C; Weisel JW; Kajani M; Rao AK
Thromb Haemost; 1997 Feb; 77(2):343-9. PubMed ID: 9157594
[TBL] [Abstract][Full Text] [Related]
43. Serological analysis of patients treated with a new surgical hemostat containing bovine proteins and autologous plasma.
Nelson PA; Powers JN; Estridge TD; Elder EA; Alea AD; Sidhu PK; Sehl LC; DeLustro FA
J Biomed Mater Res; 2001; 58(6):710-9. PubMed ID: 11745525
[TBL] [Abstract][Full Text] [Related]
44. Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin.
Rapaport SI; Zivelin A; Minow RA; Hunter CS; Donnelly K
Am J Clin Pathol; 1992 Jan; 97(1):84-91. PubMed ID: 1728869
[TBL] [Abstract][Full Text] [Related]
45. Left ventricular assist system recipients exposed to bovine thrombin preparations have a higher frequency of antiphospholipid antibodies than nonexposed recipients.
Fastenau DR; Wagenknecht DR; Hormuth DA; McIntyre JA
ASAIO J; 2001; 47(5):537-40. PubMed ID: 11575833
[TBL] [Abstract][Full Text] [Related]
46. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
47. Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus.
Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y
Lupus; 1995 Dec; 4(6):472-6. PubMed ID: 8749570
[TBL] [Abstract][Full Text] [Related]
48. A review of three stand-alone topical thrombins for surgical hemostasis.
Cheng CM; Meyer-Massetti C; Kayser SR
Clin Ther; 2009 Jan; 31(1):32-41. PubMed ID: 19243705
[TBL] [Abstract][Full Text] [Related]
49. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.
Pengo V; Biasiolo A; Brocco T; Tonetto S; Ruffatti A
Thromb Haemost; 1996 May; 75(5):721-4. PubMed ID: 8725712
[TBL] [Abstract][Full Text] [Related]
50. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
[TBL] [Abstract][Full Text] [Related]
51. Antibodies to topical bovine thrombin correlate with access thrombosis.
Sands JJ; Nudo SA; Ashford RG; Moore KD; Ortel TL
Am J Kidney Dis; 2000 May; 35(5):796-801. PubMed ID: 10793011
[TBL] [Abstract][Full Text] [Related]
52. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels.
Vlachoyiannopoulos PG; Beigbeder G; Dueymes M; Youinou P; Hunt JE; Krilis SA; Moutsopoulos HM
Autoimmunity; 1993; 16(4):245-9. PubMed ID: 8025204
[TBL] [Abstract][Full Text] [Related]
53. Measurement of antiphospholipid antibody by ELISA using purified beta 2-glycoprotein I in preeclampsia.
Yamamoto T; Yoshimura S; Geshi Y; Sasamori Y; Okinaga S; Kobayashi T; Mori H
Clin Exp Immunol; 1993 Oct; 94(1):196-200. PubMed ID: 8403506
[TBL] [Abstract][Full Text] [Related]
54. Phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies and antiphospholipid syndrome.
Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y
Intern Med; 1996 Feb; 35(2):105-10. PubMed ID: 8680096
[TBL] [Abstract][Full Text] [Related]
55. Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome.
Lee RM; Emlen W; Scott JR; Branch DW; Silver RM
Am J Obstet Gynecol; 1999 Sep; 181(3):642-8. PubMed ID: 10486478
[TBL] [Abstract][Full Text] [Related]
56. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
57. Antibodies to beta 2-glycoprotein-I: urea resistance, binding specificity, and association with thrombosis.
Vlachoyiannopoulos PG; Petrovas C; Tektonidou M; Krilis S; Moutsopoulos HM
J Clin Immunol; 1998 Nov; 18(6):380-91. PubMed ID: 9857282
[TBL] [Abstract][Full Text] [Related]
58. Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome.
de Larrañaga GF; Forastiero RR; Carreras LO; Alonso BS
Thromb Res; 1999 Oct; 96(1):19-25. PubMed ID: 10554081
[TBL] [Abstract][Full Text] [Related]
59. Topical bovine thrombin and adverse events: a review of the literature.
Clark J; Crean S; Reynolds MW
Curr Med Res Opin; 2008 Jul; 24(7):2071-87. PubMed ID: 18549663
[TBL] [Abstract][Full Text] [Related]
60. Exposure of mice to topical bovine thrombin induces systemic autoimmunity.
Schoenecker JG; Johnson RK; Lesher AP; Day JD; Love SD; Hoffman MR; Ortel TL; Parker W; Lawson JH
Am J Pathol; 2001 Nov; 159(5):1957-69. PubMed ID: 11696457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
